anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

172,021-172,080 of 319,975

filter-aware
57
Data as of December 31, 2020, from the 2020 Universal Registration Document.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
58
Kering | ESG Presentation Deck | 79 slidesKering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
59
The slide uses a numbered list format to outline four strategic pillars for human capital management.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
60
The slide uses a donut chart to represent three distinct metrics (55% Board, 55% Managers, 33% Exec Committee).Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
61
Includes a screenshot of an internal HR training module and a score from the France Equal Pay Index.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
62
Includes visual references to digital training, glossaries, and podcasts.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
63
The slide displays five smartphone mockups showing various internal and external digital assets related to Pride, Native American History, and Black History Month.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
64
The slide uses a series of logos and corresponding descriptive text to highlight ESG performance.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
65
The slide uses icons to categorize three main pillars: Continuous Learning, Talent Development, and Talent Mobility.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
66
The slide showcases four distinct mobile interface designs used for internal talent development communication.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
67
Kering | ESG Presentation Deck | 79 slidesKering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
68
The central hub contains the core message, while spokes represent specific engagement areas.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
69
Includes a testimonial from Béatrice Lazat and visual branding for the 'baby leave' initiative.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
70
Includes a screenshot of a digital platform and a graphic featuring 'superhero' themed employee roles.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
71
The slide displays a collage of video thumbnails from internal corporate communication platforms, highlighting engagement metrics like views, comments, and questions.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
72
The slide uses a 'Pass it on' campaign theme to showcase internal culture and diversity/inclusion efforts.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
73
The slide uses a laptop mockup to frame a LinkedIn-style post by Marie-Claire Daveu.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
74
The slide uses a funnel-like diagram to show how strategic goals are enabled by a core of mindset, roles, processes, and systems, supported by specific digital platforms.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
75
Kering | ESG Presentation Deck | 79 slidesKering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
76
The slide distinguishes between standard LTI and exceptional remuneration using color coding.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
77
The slide distinguishes between standard LTI and Exceptional remuneration using color coding.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
78
The slide outlines the specific financial and operational constraints for the company's share buyback program.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
79
The table lists various financial authorizations, all of which are currently marked as 'Unused'.Kering | ESG Presentation Deck | 79 slides · Kering
Conference presentation Investor relations 1 hit
01
Slide 1
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Attention1 hit
02
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Attention1 hit
03
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Attention1 hit
04
Uses a contrast-pairs framework to position the Proteome as a more dynamic and treatable target than the Genome.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Interest1 hit
05
The slide uses a 3-step process diagram to illustrate the biological mechanism of protein degradation.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · Interest1 hit
06
Uses a visual metaphor of a pie chart/wedge to represent the 'druggable' vs 'undrugged' proteome.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
07
Uses a timeline-style visual to contrast established modalities with the emerging TPD field.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
08
Includes a mix of internal Kymera leadership and one external partner (Sanofi).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
09
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
10
The slide features a stylized '5' logo, likely commemorating the company's 5th anniversary (est. 2016).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · InterestLoop · Logic Chain1 hit
11
The slide uses a bulleted list to highlight key company attributes, including their focus on Targeted Protein Degradation (TPD).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
12
The slide uses a Gantt-chart style layout to show the progression of various drug programs from discovery through clinical phases.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
13
The slide uses a five-column layout to categorize the company's strategic approach.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
14
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
15
The slide uses a split-timeline approach with drug development milestones above the line and corporate/financing events below.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
16
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
17
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
18
Kymera | Investor Day Presentation Deck | 105 slidesKymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
19
Presented by Jared Gollob, M.D., Chief Medical Officer at Kymera R&D Day.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
20
The slide uses a biological pathway diagram to illustrate the Myddosome complex and the specific advantage of a degrader over an inhibitor.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations Beat · DesireLoop · Logic Chain1 hit
21
Includes a mechanism of action diagram, a market data table, and a summary of limitations of current therapies.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
22
Data shows significant upregulation of IRAK4 in lesional skin compared to healthy controls across multiple cell types and measurement methods.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
23
Data source: Alavi et al., Society for Investigative Dermatology Annual Meeting, 2021.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
24
The left chart is a volcano plot showing selectivity; the right chart is a dose-response curve comparing the degrader to a kinase inhibitor.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
25
Includes bar charts for degradation and physiological markers, plus a line chart for EAE clinical scores.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
26
The slide outlines a clinical trial methodology involving healthy volunteers (HV) and patients across SAD and MAD cohorts.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
27
SAD = Single Ascending Dose; MAD = Multiple Ascending Dose.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
28
The chart displays mean (± SE) percent IRAK4 change from baseline. P-values are relative to placebo.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
29
The slide uses a process flow diagram to explain the experimental procedure.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
30
Data shows mean percentage change from baseline for various cytokines (IFNy, IL1b, IL6, IL8, IL10, IL12, IL17, TNFa).Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
31
The table uses checkmarks to indicate inhibition activity across different targets and stimuli.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
32
SAD = Single Ascending Dose; AE = Adverse Event; SAE = Serious Adverse Event.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
33
The slide compares Day 1 and Day 14 PK profiles, highlighting the accumulation and steady-state achievement.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
34
Data beyond day 14 is noted as pending.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
35
Data shows high efficacy at lower doses with a plateau effect observed at 100mg.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
36
The slide compares IRAK4 reduction percentages across two cell types (lymphocytes and monocytes) at Day 7 and Day 14 for various dosage groups.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit
37
Data shows significantly higher accumulation in skin tissue compared to plasma at trough levels.Kymera | Investor Day Presentation Deck | 105 slides · Kymera
Conference presentation Investor relations 1 hit